Koers Biocept Inc Nasdaq
Aandelen
US09072V1052
Medische apparatuur, benodigdheden & distributie
Omzet 2021 | 61,25 mln. 56,3 mln. | Omzet 2022 | 25,86 mln. 23,77 mln. | Marktkapitalisatie | 9,04 mln. 8,31 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -2 mln. -1,84 mln. | Nettowinst (verlies) 2022 | -32 mln. -29,41 mln. | EV/omzet 2021 | 0,73 x |
Nettoliquiditeiten 2021 | 16,19 mln. 14,88 mln. | Nettoliquiditeiten 2022 | 788K 724K | EV/omzet 2022 | 0,32 x |
K/w-verhouding 2021 |
-18,9
x | K/w-verhouding 2022 |
-0,28
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 100% |
Recentste transcriptie over Biocept Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Barbara Blouw
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-20 |
Nathaniel Sweed
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | 60 | 08-03-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,62% | 12,18 mld. | |
+8,48% | 5,96 mld. | |
+27,77% | 5,45 mld. | |
-6,28% | 4,34 mld. | |
-52,59% | 3,18 mld. | |
+12,93% | 2,75 mld. | |
+31,19% | 2,3 mld. | |
-3,80% | 2,28 mld. | |
-4,64% | 1,92 mld. |